Manju L. Subramanian, MD
Associate Professor
Boston University School of Medicine
Dept of Ophthalmology

MD, University of Missouri School of Medicine



Dr. Subramanian is an Ophthalmic surgeon specializing in Vitreoretinal Disease and Surgery. Her primary areas of clinical interest include medical and surgical management of diabetic retinopathy, age-related macular degeneration, retinal detachments, hereditary retinal diseases, ocular inflammation, and ocular trauma. She sees patients at Boston Medical Center and Dedham Ophthalmic Consultants. Dr. Subramanian graduated from the University of Missouri School of Medicine and completed her residency at the University of Kansas Medical Center. She completed a fellowship in Vitreoretinal Disease and Surgery at Tufts University School of Medicine and Ophthalmic Consultants of Boston. She is currently in clinical practice and has been seeing patients and operating since 2004.

Dr. Subramanian is the Vice-Chairman of Faculty Affairs at Boston University Eye Associates, where she works in a supportive role for the professional development and engagement of the clinical faculty, since 2017. Prior to that, she served as the Vice-Chairman of Clinical Services for 8 years. Her research interests include age-related macular degeneration, diabetic retinopathy, the role of anesthesia in eye surgery, and the study of inflammatory and Alzheimer’s biomarkers in the eye. She ran the first head to head clinical trial comparing the use of bevacizumab and ranibizumab in the treatment of age-related macular degeneration, and she is currently the principal investigator for a study assessing the role of oral sedation in eye surgery.

2006 Boston University School of Medicine: Outstanding Clinical Instructor
2002 University of Missouri: Resident of the Year Award
1995 University of Missouri: Jack Gant Award
1994 University of Missouri: Flarsheim Student Teaching Assistantship Award
1993 University of Missouri: Jack Gant Award
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

  1. Cho J, Siegel N, Subramanian ML, Ying H, Ness S. RAPIDLY PROGRESSIVE NEOVASCULAR GLAUCOMA FROM CYTOMEGALOVIRUS RETINITIS IN A NON-HUMAN IMMUNODEFICIENCY VIRUS PATIENT. Retin Cases Brief Rep. 2018 Mar 12.View Related Profiles. PMID: 29533389.
     
  2. Thanos A, Miller JB, Ma KN, Subramanian ML, Kim IK, Eliott D. A New Variant of Polypoidal Choroidal Vasculopathy With Annular Pigmentary Changes in Haitian Males. Ophthalmic Surg Lasers Imaging Retina. 2016 Apr 01; 47(4):381-6. PMID: 27065382; DOI: 10.3928/23258160-20160324-15;.
     
  3. Seethala A, Ness S, Subramanian M. Current Treatments in Diabetic Macular Edema. Journal of Endocrinol Diabetes. 2015. View Publication
  4. Moja L, Lucenteforte E, Kwag KH, Bertele V, Campomori A, Chakravarthy U, D'Amico R, Dickersin K, Kodjikian L, Lindsley K, Loke Y, Maguire M, Martin DF, Mugelli A, Mühlbauer B, Püntmann I, Reeves B, Rogers C, Schmucker C, Subramanian ML, Virgili G. Systemic safety of bevacizumab versus ranibizumab for neovascular age-related macular degeneration. Cochrane Database Syst Rev. 2014 Sep 15; (9):CD011230. PMID: 25220133; PMCID: PMC4262120; DOI: 10.1002/14651858.CD011230.pub2;.
     
  5. Subramanian M. Decision Making in Ophthalmology: An Algorithmic Approach. White Spots in the Fundus. Jaypee Brothers Medical Publishers. New Delhi. 2014.
  6. Siegel NH, Subramanian M. Integrated approaches in drug discovery and development (Jianling Wang and Laszo Urban, eds.). Safety Management by Pharmacokinetic Considerations: Ranibizumab (Lucentis) and Bevacizumab (Avastin)” Predictive ADMET. Wiley. Hoboken. 2014.
  7. Antonopoulos C, Subramanian M. Diabetic Retinopathy (Mohammad Shamsul Ola,ed.). Diabetic Macular Edema. InTech. London. 2012.
  8. Abedi G, Doros G, Subramanian ML. Transitioning from Stratus OCT to Cirrus OCT using Lin's concordance coefficient. Graefes Arch Clin Exp Ophthalmol. 2013 Jan; 251(1):411-2.View Related Profiles. PMID: 22215256; DOI: 10.1007/s00417-011-1899-y;.
     
  9. Abedi G, Patal P, Doros G, Subramanian ML. Transitioning from stratus OCT to cirrus OCT: a comparison and a proposed equation to convert central subfield macular thickness measurements in healthy subjects. Graefes Arch Clin Exp Ophthalmol. 2011 Sep; 249(9):1353-7.View Related Profiles. PMID: 21720815; DOI: 10.1007/s00417-011-1725-6;.
     
  10. Abedi G, Subramanian ML, Feinberg E, Ness SD. The role of intravenous immunoglobulin in treatment of acute retinal necrosis. Retin Cases Brief Rep. 2011; 5(4):363-5.View Related Profiles. PMID: 25390437; DOI: 10.1097/ICB.0b013e318217383b;.
     
Showing 10 of 38 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 38 publications over 18 distinct years, with a maximum of 7 publications in 2009

YearPublications
19951
19991
20011
20021
20034
20041
20051
20062
20071
20082
20097
20106
20112
20122
20143
20151
20161
20181
In addition to these self-described keywords below, a list of MeSH based concepts is available here.

Age related macular degeneration
Diabetic Retinopathy
Ocular Trauma
Retinal Detachments
Hereditary Retinal and Macular Diseases

Available to Mentor as: (Review Mentor Role Definitions):
  • Career Mentor
  • Work / Life Integration Mentor
Contact for Mentoring:


85 E. Concord St
Boston MA 02118
Google Map


Subramanian's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Co-Authors
_
Similar People
_
Same Department